Upper respiratory microbiome and host immune signatures associated with SARS-CoV-2 susceptibility and illness in a human challenge model

The upper respiratory tract (URT) microbiome modulates the local mucosal immune environment, with potential implications for respiratory viral infection susceptibility and outcomes. We leveraged a first–in–human SARS–CoV–2 challenge study in 34 healthy young adults, 18 of whom became infected, to characterize host gene expression and microbiome composition and dynamics in nasal and throat samples collected before viral inoculation and over the subsequent 14 days. Compared with participants who remained uninfected, participants who became infected had elevated baseline nasal expression of gene modules related to interferon, innate inflammatory, and neutrophil responses, as well as a delayed transcriptional response to viral challenge. Baseline nasal microbiome composition differed modestly by subsequent infection status, with lower relative abundances of Corynebacterium accolens and higher abundances of Dolosigranulum pigrum and Staphylococcus aureus among participants who became infected. Integrated analyses of microbiome and host gene expression data identified coordinated networks of microbiome features and host immune modules that distinguished infected from uninfected participants, including prior to inoculation. Notably, immune modules associated with infection susceptibility were positively correlated with S. aureus abundance and negatively correlated with the abundances of common nasal commensals, Corynebacterium spp. and Staphylococcus epidermidis , linking altered nasal microbiome community structure with the heightened inflammatory state associated with infection susceptibility. Symptom burden and viral load were similarly linked to distinct networks of microbiome and host gene expression features within nasal samples. Taken together, these findings highlight potential microbiome–host interactions within the nasal mucosa that may contribute to differences in respiratory viral infection outcomes.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-11-19
DOI
https://doi.org/10.64898/2026.11.16.26368138
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Upper respiratory microbiome and host immune signatures associated with SARS-CoV-2 susceptibility and illness in a human challenge model

Visanu Wanchai, Ben Killingley, Intawat Nookaew, Alex Mann et al.
medRxiv
SARS-CoV-2 and COVID-19 Research
preprint

Upper respiratory microbiome and host immune signatures associated with SARS-CoV-2 susceptibility and illness in a human challenge model

Visanu Wanchai, Ben Killingley, Intawat Nookaew, Alex Mann, Christopher Chiu, Devjanee Swain-Lenz, Kristine L. Kay, Jillian H. Hurst, Helen R. Wagstaffe, Jason W. Arnold, Matthew S. Kelly, Pixu Shi, Mariya Kalinova, So Young Kim, Andrew P. Catchpole, Laura Leigh S Rowlette, Sarah Cleaton, Corbin Hite
preprint en

Abstract

The upper respiratory tract (URT) microbiome modulates the local mucosal immune environment, with potential implications for respiratory viral infection susceptibility and outcomes. We leveraged a first–in–human SARS–CoV–2 challenge study in 34 healthy young adults, 18 of whom became infected, to characterize host gene expression and microbiome composition and dynamics in nasal and throat samples collected before viral inoculation and over the subsequent 14 days. Compared with participants who remained uninfected, participants who became infected had elevated baseline nasal expression of gene modules related to interferon, innate inflammatory, and neutrophil responses, as well as a delayed transcriptional response to viral challenge. Baseline nasal microbiome composition differed modestly by subsequent infection status, with lower relative abundances of Corynebacterium accolens and higher abundances of Dolosigranulum pigrum and Staphylococcus aureus among participants who became infected. Integrated analyses of microbiome and host gene expression data identified coordinated networks of microbiome features and host immune modules that distinguished infected from uninfected participants, including prior to inoculation. Notably, immune modules associated with infection susceptibility were positively correlated with S. aureus abundance and negatively correlated with the abundances of common nasal commensals, Corynebacterium spp. and Staphylococcus epidermidis , linking altered nasal microbiome community structure with the heightened inflammatory state associated with infection susceptibility. Symptom burden and viral load were similarly linked to distinct networks of microbiome and host gene expression features within nasal samples. Taken together, these findings highlight potential microbiome–host interactions within the nasal mucosa that may contribute to differences in respiratory viral infection outcomes.

medRxiv
University of Nottingham (GB), Duke University (US), hVIVO (United Kingdom) (GB), Duke Medical Center (US), Imperial College London (GB), University of Arkansas for Medical Sciences (US)
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon